FDA Drug Recalls

Recalls / Class II

Class IID-1067-2020

Product

Ibuprofen 50 mg per 1.25 mL Oral Suspension Advil Infant Concentrated Drops White Grape 0.75 oz. and 1 oz. bottles NDC 0573-0191-75 (0.75 oz.) NDC 0573-0191-50 (1 oz.)

Brand name
Infants Advil
Generic name
Ibuprofen
Active ingredient
Ibuprofen
Route
Oral
NDC
0573-0191
FDA application
NDA020812
Affected lot / code info
Batch/Lot # R73761, exp. date 01/31/2021, Item # F00573019175, 0.75 oz. R74936, exp. date 02/28/2021, Item # F00573019175, 0.75 oz. R56290, exp. date 03/31/2020, Item # F00573019150, 1 oz. R60959, exp. date 02/28/2021, Item # F00573019150, 1 oz. R78826, exp. date 11/30/2021, Item # F00573019150, 1 oz. 9335UA, exp. date 01/31/2021, item # F00573019175A - Co-package 9336UA, exp. date 02/28/2021, item # F00573019175A - Co-package

Why it was recalled

Labeling: Lacks Warning or Rx Legend- Certain lots does not include required safety warning information in the Drug Facts Panel.

Recalling firm

Firm
Glaxosmithkline Consumer Healthcare Holdings
Manufacturer
Haleon US Holdings LLC
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
184 Liberty Corner Rd, N/A, Warren, New Jersey 07059-6796

Distribution

Quantity
151,056 bottles
Distribution pattern
Product was distributed throughout the United States, including Puerto Rico.

Timeline

Recall initiated
2020-03-16
FDA classified
2020-03-26
Posted by FDA
2020-04-01
Terminated
2021-10-28
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-1067-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.